High dose oral supplementation is an effective alternative to parenteral treatment Randomized studies of daily high oral doses of 1,0002,000 g have shown equivalence or superiority to injected B 12
Aseptic Preparation and Storage: Principles for Clinical Trial Settings Reconstitution of injectable investigational products must be performed by trained personnel following the trial protocol, using the specified diluent, in an appropriate aseptic environment
It is provided in a pre-configured laboratory format for in-vitro research use only, not for human or veterinary use
The final conversion of ingested protein into amino acids and very short peptides that can be absorbed into the bloodstream takes place in the intestines
The FDA also expects manufacturers whose COVID-19 vaccines are authorized under an EUA to continue their clinical trials to obtain additional safety and effectiveness information and pursue approval (licensure).
How are Vitamin B12 injections administered